查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970855

非侵入性腦損傷監測設備市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用途、地區和競爭對手分類，2021-2031年

Non-invasive Brain Trauma Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球非侵入性腦損傷監測設備市場預計將從 2025 年的 149.3 億美元大幅成長至 2031 年的 240.4 億美元，複合年成長率為 8.26%。

這些專用醫療設備旨在評估顱內壓、腦血流量和腦電活動等關鍵參數，無需手術切口或植入侵入性感測器。市場成長的主要驅動力是全球範圍內由跌倒、車禍和運動相關衝擊導致的創傷性腦損傷 (TBI) 病例的增加。所有這些都需要安全快速的診斷解決方案。這些事件的高發生率凸顯了這種迫切性。根據美國腦損傷協會的數據，到 2025 年，美國約有十分之四的成年人會在頭部受傷後出現與腦損傷相關的症狀。

市場概覽
預測期 2027-2031
市場規模：2025年 149.3億美元
市場規模：2031年 240.4億美元
複合年成長率：2026-2031年 8.26%
成長最快的細分市場 醫院
最大的市場 北美洲

儘管市場前景廣闊，但仍面臨一個重大障礙：圍繞非侵入式系統與侵入式黃金標準相比的準確性和可靠性的爭論。神經外科醫生和重症監護醫生在僅依賴非侵入式數據做出影響患者生死的重要臨床決策時往往十分謹慎，因為生理變異會影響感測器的準確性。因此，這些對測量準確性的擔憂阻礙了監管部門的核准，並限制了醫院將這些技術應用於日常患者照護的速度。

市場促進因素

全球創傷性腦損傷 (TBI) 發生率的不斷上升是推動非侵入性腦損傷監測設備市場發展的主要因素。隨著車禍、跌倒等高衝擊性事件的日益頻繁，人們迫切需要能夠即時進行診斷的手段，而這些手段無法透過需要在無菌手術環境下進行的侵入性方法來實現。這種需求促使人們尋求能夠在急診室和院前環境中快速部署的表面監測工具，從而加速早期醫療干預。美國疾病管制與預防中心 (CDC) 2024 年 1 月的監測報告進一步印證了這種緊迫性，該報告顯示，美國每年有超過 69,000 人死於與 TBI 相關的疾病。這凸顯了能夠獨立於神經外科基礎設施運作的分流工具的重要性。

此外，攜帶式和穿戴式監測系統的技術進步正在拓展腦部監測的效用，使其不再局限於傳統的加護病房（ICU），從而推動市場成長。近紅外線光譜（NIRS）和腦電圖（EEG）技術的創新使得設備體積更小，能夠在臨床環境中對顱內壓和腦電活動進行連續、直接的評估。這項發展使得在救護車和運動診所等場所進行即時數據收整合為可能，有效克服了固定式侵入性設備的限制。 Ceribell公司於2024年9月提交的一份報告便是這種快速臨床應用的一個典型例證，該報告指出，其人工智慧驅動的攜帶式腦電圖系統已評估了超過10萬名患者。人口趨勢也進一步推動了這一成長。根據世界衛生組織（WHO）2024年的報告，全球每年約有3730萬人因跌倒需要醫療干預，這為這些用途廣泛、非侵入性的解決方案提供了穩定的患者來源。

市場挑戰

全球無創腦損傷監測市場發展面臨的主要障礙之一是神經外科醫師對非侵入性方法與侵入性顱內壓監測相比的準確性和可靠性持續持懷疑態度。在重症監護環境中，絕對準確性至關重要，而非侵入性技術由於易受生理因素（例如頭皮水腫和顱骨厚度變化）的訊號干擾，往往需要經過嚴格的檢驗。這種技術上的不確定性迫使醫務人員在生死攸關的決策中依賴現有的有創方法，從而極大地限制了非侵入性替代方案在急診和加護病房的臨床應用。

因此，這種信心的不足導致監管核准流程和醫院採購週期雙雙放緩，阻礙了市場充分滿足對便捷的創傷性腦損傷（TBI）管理工具的迫切經濟需求。治療不足造成的經濟損失十分嚴重，這使得那些未經實驗驗證的技術檢驗市場認可。根據美國外科醫師學會估計，到2024年，全球創傷性腦損傷造成的經濟負擔將高達每年4,000億美元。在非侵入性設備能夠被證實達到黃金標準的準確性之前，這種臨床上的猶豫不決將繼續限制其收入潛力和市場佔有率。

市場趨勢

人工智慧 (AI) 在預測分析領域的應用正在改變市場格局，使設備從被動監測工具轉變為主動、即時的臨床決策支援系統。製造商正加速將機器學習演算法整合到非侵入式平台中，以便在出現身體症狀之前識別細微的神經模式並繪製大腦功能圖。這項進步對於在複雜的醫療環境中實現主動決策至關重要，並將技術從簡單的觀察轉變為先進的診斷指導。 News-Medical.net 在 2025 年 6 月的一篇新聞報道便是監管和技術進步的一個鮮明例證。該報告指出，Sora 食品藥物管理局的人工智慧驅動軟體 Cirrus 已獲得 FDA核准，該軟體能夠以非侵入式方式識別功能性腦部網路。

同時，專注於運動專案腦震盪管理解決方案的趨勢正在形成一個獨特的細分市場，其驅動力來自預防性醫療保健目標和職業運動的需求。設備開發商和體育聯盟正優先採用能夠追蹤頭部撞擊暴露情況的技術，並透過改進設備和更嚴格的規則執行來降低受傷率，從而創建一種不同於緊急創傷監測的護理模式。這一趨勢正在取得切實的安全成效。根據美國國家橄欖球聯盟（NFL）2025年2月發布的報告，NFL橄欖球運營部門報告稱，與上賽季相比，聯盟內確診的腦震盪病例減少了17%。這項突破性成就歸功於數據驅動通訊協定和先進安全技術的廣泛應用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球非侵入性腦損傷監測設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品分解（監控設備、耗材）
    • 透過申請（醫院、神經科中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美非侵入性腦損傷監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲非侵入性腦損傷監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區非侵入性腦損傷監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲非侵入性腦損傷監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲非侵入性腦損傷監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球非侵入性腦損傷監測設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Advanced Brain Monitoring, Inc.
  • Cadwell Industries, Inc.
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Magstim, Inc
  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • Medtronic Plc
  • Siemens Healthineers AG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25348

The Global Non-invasive Brain Trauma Monitoring Devices Market is projected to expand significantly, rising from a valuation of USD 14.93 Billion in 2025 to USD 24.04 Billion by 2031, reflecting a compound annual growth rate of 8.26%. These specialized medical instruments are engineered to assess critical parameters such as intracranial pressure, cerebral blood flow, and electrical activity without the need for surgical incisions or invasive sensor placement. The market's momentum is largely propelled by the escalating global prevalence of traumatic brain injuries (TBIs) stemming from falls, vehicular collisions, and sports-related impacts, all of which demand safe and immediate diagnostic solutions. This urgent need is highlighted by the high incidence of such events; data from the Brain Injury Association of America indicates that in 2025, approximately four out of ten adults in the United States reported experiencing symptoms associated with brain injuries following head trauma.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 14.93 Billion
Market Size 2031USD 24.04 Billion
CAGR 2026-20318.26%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Despite these growth prospects, the market faces a substantial obstacle regarding the debate over the accuracy and reliability of non-invasive systems when compared to the invasive gold standard. Neurosurgeons and critical care specialists frequently exercise caution before depending exclusively on non-invasive data for life-altering clinical decisions, as physiological variations can compromise sensor precision. Consequently, these concerns about measurement fidelity impede regulatory approvals and limit the rate at which hospitals adopt these technologies for routine patient care.

Market Driver

The escalating global incidence of traumatic brain injuries acts as a primary engine for the growth of the non-invasive brain trauma monitoring devices market. As high-impact events like automobile accidents and falls become more frequent, there is an imperative need for immediate diagnostic capabilities that invasive methods, which require sterile surgical environments, cannot offer. This necessity drives the demand for surface-based monitoring tools capable of rapid deployment in emergency rooms and pre-hospital scenarios to support early medical intervention. The urgency is underscored by data from the Centers for Disease Control and Prevention's January 2024 surveillance report, which notes that there are over 69,000 TBI-related deaths annually in the United States, highlighting the critical need for triage tools capable of operating independently from neurosurgical infrastructure.

Furthermore, technological breakthroughs in portable and wearable monitoring systems are catalyzing market expansion by extending the utility of brain monitoring beyond traditional intensive care units. Innovations in near-infrared spectroscopy and electroencephalography have led to device miniaturization, enabling continuous assessment of intracranial pressure and electrical activity directly at the point of care. This evolution allows for real-time data acquisition in ambulances and sports clinics, effectively overcoming the constraints of stationary, invasive equipment. A testament to this rapid clinical uptake is found in Ceribell, Inc.'s September 2024 filing, which reported that their portable AI-powered EEG system has assessed over 100,000 patients. This adoption is further driven by demographic trends; the World Health Organization reported in 2024 that approximately 37.3 million falls requiring medical attention occur globally each year, ensuring a steady stream of patients for these versatile non-invasive solutions.

Market Challenge

A major hurdle hindering the progress of the Global Non-invasive Brain Trauma Monitoring Devices Market is the enduring skepticism among neurosurgeons regarding the precision and reliability of these devices relative to invasive intracranial pressure monitoring. Because critical care demands absolute accuracy, non-invasive technologies often face scrutiny due to signal interference arising from physiological factors like scalp edema and varying skull thickness. This technical uncertainty compels medical professionals to rely on established invasive procedures for life-critical decisions, thereby significantly restricting the clinical uptake of non-invasive alternatives within emergency settings and intensive care units.

As a result, this lack of confidence decelerates both regulatory approval processes and hospital procurement cycles, preventing the market from fully addressing the urgent economic necessity for accessible TBI management tools. The financial implications of inadequate treatment are severe, creating high barriers for technologies viewed as experimentally unproven. According to the American College of Surgeons, the global economic burden of traumatic brain injury was estimated at $400 billion annually in 2024. Until non-invasive devices can convincingly demonstrate fidelity comparable to the gold standard, this clinical hesitation will continue to constrain their revenue potential and market share.

Market Trends

The integration of Artificial Intelligence for predictive analytics is transforming the market by elevating devices from passive monitoring tools to active, real-time clinical decision support systems. Manufacturers are increasingly incorporating machine learning algorithms into non-invasive platforms to identify subtle neurological patterns and map brain function prior to the onset of physical deterioration symptoms. This advancement is vital for enabling proactive decision-making in complex care environments, transitioning the technology from simple observation to advanced diagnostic guidance. A clear indication of this regulatory and technological progress is highlighted by News-Medical.net in June 2025, which reported that Sora Neuroscience received FDA clearance for its AI-driven Cirrus software to non-invasively identify functional brain networks.

Concurrently, a specialized focus on sports-specific concussion management solutions is carving out a distinct market segment driven by preventative health goals and professional athletic mandates. Device developers and sports leagues are prioritizing technologies that track head impact exposure and mitigate injury rates through enhanced equipment and strict rule enforcement, creating a care model separate from emergency trauma monitoring. This trend is delivering tangible safety outcomes; according to a February 2025 report by NFL Football Operations, the league observed a 17% reduction in diagnosed concussions compared to the previous season, a milestone credited to the widespread implementation of data-driven protocols and advanced safety technologies.

Key Market Players

  • Advanced Brain Monitoring, Inc.
  • Cadwell Industries, Inc.
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Magstim, Inc
  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Medtronic Plc
  • Siemens Healthineers AG

Report Scope

In this report, the Global Non-invasive Brain Trauma Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-invasive Brain Trauma Monitoring Devices Market, By Product

  • Monitoring Devices
  • Consumables

Non-invasive Brain Trauma Monitoring Devices Market, By End-use

  • Hospitals
  • Neurological Centres
  • Others

Non-invasive Brain Trauma Monitoring Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-invasive Brain Trauma Monitoring Devices Market.

Available Customizations:

Global Non-invasive Brain Trauma Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Monitoring Devices, Consumables)
    • 5.2.2. By End-use (Hospitals, Neurological Centres, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-use

7. Europe Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End-use

8. Asia Pacific Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-use

10. South America Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Non-invasive Brain Trauma Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Advanced Brain Monitoring, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cadwell Industries, Inc.
  • 15.3. Canon Medical Systems Corporation
  • 15.4. Compumedics Limited
  • 15.5. Magstim, Inc
  • 15.6. General Electric Company
  • 15.7. Hitachi, Ltd.
  • 15.8. Koninklijke Philips N.V.
  • 15.9. Medtronic Plc
  • 15.10. Siemens Healthineers AG

16. Strategic Recommendations

17. About Us & Disclaimer